GovChime
Notice ID: 7b8925a49ab84a85b0f52548ac8f8db9Combined Synopsis/Solicitation

4D Nucleofector Transfection Instrument

Archived on September 18, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
August 27, 2024
Notice type
Combined Synopsis/Solicitation
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Place of performance
Bethesda, MD, 20892
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75N95024Q00414
Notice ID
7b8925a49ab84a85b0f52548ac8f8db9

Description

The National Institute of Neurological Disorders andStroke (NINDS) requires a brand name or equal 4D Nucleofector system andcomponent parts for genome engineering of human induced pluripotent stem cells(hiPSCs) using CRISPR-Cas9 technology. NINDS requires a system that will provideprecise and efficient gene editing tools, especially for applications in regenerativemedicine and disease modeling. NINDS requires a 4D Nucleofector that allows forprecise and efficient gene editing tools, especially for applications in regenerativemedicine and disease modeling. NINDS intends to utilize this system for the introductionof CRISPR Cas9 RNPs into iPSCs to introduce neurodegeneration related mutations.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95024Q00414
  1. Market Research
  2. Combined Synopsis
  1. Market ResearchJul 12, 2024

    Electroporation-based Transfection Instrument

    Notice 96c9566081864cdd9d1566940fe0a777 on SAM.gov

  2. Combined SynopsisCurrentAug 27, 2024

    4D Nucleofector Transfection Instrument

    Notice 7b8925a49ab84a85b0f52548ac8f8db9 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95024Q00414

Archive Date

Sep 18, 2024

Office Address

Bethesda, MD, 20892